age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
44.05197
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 26
| 121,420.875
| 92,187.5
| null | 51
|
white
| 38.398438
| 68
| 0.432983
| 0.312988
| 6
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 51
| 9.898438
| 60
| 31
| 40.09375
| 283.3125
| 3.299805
| 12
| 3
| 133
| 7.419922
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
70.14899
|
female
| 1
| 4
|
Coma
|
Coma
| 1
| 7
| null | 100
| 83,997.625
| 51,037.4375
| null | 14
|
white
| 22.699219
| 43
| 0.097992
| 0.058998
| 20
| 1
| 0
|
no
| null | null |
dnr after sadm
| 2
| 70
| 16.597656
| 64
| 28
| 38.5
| 220
| 2.5
| 1.099854
| 2.699707
| 135
| 7.579102
| null | null | null | null | null |
<2 mo. follow-up
| 2.46875
| 4
| 1
|
69.66498
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 11
| null | 0
| 4,562.496
| 3,465.2734
| null | 10
|
white
| 17.597656
| 34
| 0.868896
| 0.782959
| 1
| 0
| 0
|
no
| 0.75
| 0.65
|
no dnr
| 9
| 107
| 9.599609
| 84
| 22
| 36.39844
| 214.28125
| 3.399902
| 0.299988
| 1.599854
| 136
| null | null | null | null | 0
| null | null | 0.4948
| 1,510
| 0
|
65.47296
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 100
| 87,248.375
| 54,247.8438
| null | 23
|
white
| 76.6875
| 86
| 0
| 0
| 21
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 0
| 11.898438
| 0
| 0
| 38.09375
| 248
| 4.099609
| 4.5
| 2.599609
| 135
| 7.459961
| null | null | null | null | null |
<2 mo. follow-up
| 1.738281
| 3
| 1
|
68.18097
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 40,095
| 26,610
| null | 37.5
|
white
| 32.695313
| 55
| 0.555908
| 0.442993
| 1
| 0
| 0
|
yes
| 0.25
| 0.15
|
dnr after sadm
| 7
| 69
| 29.597656
| 122
| 34
| 36.79688
| 72
| 1.399902
| null | 0.699951
| 139
| 7.539062
| null | null | null | null | null |
<2 mo. follow-up
| 2.14502
| 9
| 1
|
75.15399
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 6,329.598
| 4,483.8203
| null | 13
|
white
| 14
| 13
| 0.880981
| 0.800903
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 9
| 107
| 5.5
| 108
| 24
| 36
| 364
| 4.299805
| 0.399963
| 0.899902
| 144
| 7.359375
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,421
| 1
|
65.42395
|
female
| 0
| 13
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$11-$25k
| 0
| 9,626.047
| 7,334.457
| null | 7.5
|
white
| 23.398438
| 23
| 0.69397
| 0.529907
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 13
| 77
| 3.599609
| 80
| 20
| 37
| null | 2.899902
| 3.5
| 0.699951
| 124
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,500
| 0
|
72.79095
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
| null | 44
| 26,893.812
| 17,477.2656
| null | 46
|
white
| 32.296875
| 49
| 0.40094
| 0.280945
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 4
| 68
| 22.296875
| 112
| 8
| 38.79688
| 151.65625
| null | 0.099991
| 7.299805
| 128
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 2.412598
| 5
| 1
|
66.146
|
male
| 1
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 7
| null | 0
| 71,331.938
| 46,761.8438
| null | 55.5
|
black
| 42
| 79
| 0.142975
| 0.066986
| 6
| 1
| 0
|
yes
| null | null |
dnr after sadm
| 5
| 53
| 1
| 160
| 40
| 36.5
| 313.3125
| 3
| 1.099854
| 5.299805
| 134
| 7.349609
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 12
| 1
|
74.89697
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 18
|
$11-$25k
| 0
| 23,341.547
| 16,540.5312
| null | 20
|
white
| 26.796875
| 36
| 0.657959
| 0.481995
| 8
| 0
| 0
|
no
| 0.98
| 0.95
|
no dnr
| 10
| 75
| 14.398438
| 96
| 12
| 36.59375
| 288
| 2.899902
| 1.199951
| 1.599854
| 131
| 7.429688
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,499
| 0
|
60.241
|
female
| 0
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 59,781.688
| 37,313
| null | 16.5
|
white
| 23
| 25
| 0.640991
| 0.539917
| 15
| 0
| 0
|
yes
| 0.8
| 0.7
|
no dnr
| 9
| 108
| 7
| 46
| 16
| 36.19531
| 396
| 1.299805
| 0.299988
| 0.599976
| 129
| 7.449219
| null | null | null | 0
| null | null | 0.4948
| 1,497
| 0
|
51.85498
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$25-$50k
| 0
| 24,805.141
| 16,157.6328
| null | 14
|
white
| 21.398438
| 14
| 0.873901
| 0.829956
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 76
| 8.5
| 114
| 24
| 36.19531
| 328
| null | null | 0.5
| 137
| 7.399414
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,497
| 0
|
43.63898
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 45,775.469
| 28,687.6094
| null | 18.666656
|
white
| 19.296875
| 16
| 0.907959
| 0.875
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 18
| 78
| 7
| 56
| 24
| 36
| 352.375
| 2.899902
| 2.099609
| 0.799927
| 139
| 7.419922
| null | null | null | null | null | null | 2.197754
| 1,496
| 0
|
40.41898
|
female
| 1
| 99
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
$25-$50k
| 0
| 363,470.25
| 238,485.375
| null | 34.75
|
white
| 34.695313
| 53
| 0.727905
| 0.644897
| 1
| 0
| 0
|
no
| 0.2
| 0.2
|
no dnr
| 99
| 69
| 14
| 114
| 26
| 37.79688
| 126.65625
| null | 1.199951
| 3.399902
| 149
| 7.469727
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 99
| 1
|
33.66998
|
male
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 14
| null | 0
| 9,953.547
| 6,871.8125
| null | 9.5
|
black
| 26
| 9
| 0.743896
| 0.47998
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.1
|
no dnr
| 10
| 107
| 17.199219
| 84
| 24
| 36.29688
| null | 2.699707
| 0.799927
| 0.799927
| 137
| null | null | null | null | 1
| 6
|
<2 mo. follow-up
| 6
| 22
| 1
|
75.66595
|
female
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
$25-$50k
| 26
| 60,396.969
| 37,721.1875
| null | 48
|
white
| 18.898438
| 33
| 0.776978
| 0.703979
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 13
| 71
| 8.5
| 64
| 40
| 38.59375
| 194.28125
| 2.199707
| null | 0.599976
| 138
| 7.369141
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 13
| 1
|
44.85999
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
under $11k
| 44
| 27,579.141
| 17,868.6094
| null | 39
|
black
| 33.796875
| 43
| 0.519897
| 0.403992
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 141
| 11.599609
| 116
| 60
| 35.39844
| 447.5625
| null | null | 0.399963
| 130
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 26
| 1
|
51.90097
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 9
|
under $11k
| 0
| 12,283.992
| 7,625.2305
| null | 27
|
black
| 24.699219
| 23
| 0.849976
| 0.75293
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 6
| 65
| 7.199219
| 64
| 26
| 36.29688
| 385.6875
| 3.199707
| 1.699951
| 1
| 126
| 7.5
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 517
| 1
|
69.06799
|
male
| 1
| 36
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$25-$50k
| 26
| 238,776
| 149,039.25
| null | 39
|
white
| 29.296875
| 51
| 0.506958
| 0.389954
| 9
| 0
| 0
|
no
| 0.25
| 0.2
|
no dnr
| 36
| 120
| 19.296875
| 110
| 25
| 38.29688
| 303.3125
| 2.799805
| 5.599609
| 7
| 138
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 36
| 1
|
30.70499
|
female
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
under $11k
| 37
| 71,635.188
| 48,012.9375
| null | 50.333313
|
other
| 34.59375
| 60
| 0.641968
| 0.540894
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 15
| 70
| 13.699219
| 156
| 36
| 41
| 125
| 2.899902
| 1.299805
| 1.599854
| 145
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 16
| 1
|
52.57498
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 3,042.049
| 2,174.0625
| null | 7
|
white
| 14.699219
| 9
| 0.775879
| 0.533936
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 4
| 115
| 12.199219
| 84
| 20
| 36.89844
| null | null | 0.799927
| 1.099854
| 139
| null | null | null | null | null | null |
adl>=4 (>=5 if sur)
| 1.958984
| 78
| 1
|
59.69598
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 2,390.049
| 1,955.835
| null | 3
|
black
| 27.5
| 32
| 0.782959
| 0.652954
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 87
| 5.5
| 110
| 20
| 35.69531
| 433.3125
| null | 4.199219
| 1.399902
| 129
| 7.519531
| null | null | null | 0
| null | null | 0.4948
| 1,488
| 0
|
65.62598
|
male
| 0
| 18
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 53,957.688
| 33,482.8438
| null | 32
|
black
| 26.296875
| 22
| 0.779907
| 0.648926
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 18
| 109
| 11.798828
| 60
| 10
| 36.79688
| 142
| null | null | 1.299805
| 128
| 7.469727
| null | null | null | 0
| 2
|
no(M2 and SIP pres)
| 2
| 626
| 1
|
62.30298
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 11
| null | 0
| 24,865.984
| 15,584.4922
| null | 22
|
white
| 21.199219
| 31
| 0.86499
| 0.775879
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 11
| 67
| null | 108
| 16
| 37
| 312
| null | 0.5
| 2.199707
| 136
| 7.40918
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 758
| 1
|
48.72299
|
female
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 44
| 115,659.5
| 75,410.1875
| null | 35.25
|
black
| 30.097656
| 53
| 0.61792
| 0.513916
| 1
| 1
| 0
|
no
| 0.25
| 0.2
|
no dnr
| 32
| 55
| 4.099609
| 130
| 14
| 39.79688
| 288
| 2.799805
| 0.199982
| 10
| 145
| 7.439453
| null | null | null | null | 0
| null | 0
| 1,488
| 0
|
79.80798
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 13
|
>$50k
| 0
| 30,417.844
| 21,071.0312
| null | 42
|
white
| 25.699219
| 40
| 0.659912
| 0.56189
| 1
| 1
| 0
|
yes
| 0.5
| 0.25
|
dnr after sadm
| 3
| 64
| 13.398438
| 50
| 6
| 37.5
| 310
| 2.5
| null | 5.099609
| 133
| 7.359375
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 8
| 1
|
55.64999
|
female
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
| null | 37
| 92,960.125
| 59,123.4375
| null | 31.5
|
white
| 24.898438
| 43
| 0.721924
| 0.635986
| 1
| 1
| 0
|
no
| 0.8
| 0.78
|
no dnr
| 37
| 63
| 17.296875
| 110
| 24
| 38
| 253.3125
| null | 0.399963
| 4.599609
| 143
| 7.429688
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 777
| 1
|
45.57397
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
$25-$50k
| 0
| 34,929.969
| 22,198.3594
| null | 12.333328
|
black
| 26.296875
| 17
| 0.816895
| 0.755981
| 3
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 15
| 80
| 12.699219
| 104
| 40
| 38.59375
| 316.625
| null | null | 0.599976
| 128
| 7.429688
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,487
| 0
|
52.16199
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 4,945.75
| 3,090.332
| null | 17
|
white
| 15.898438
| 11
| 0.755981
| 0.5
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 107
| 10
| 75
| 16
| 35.79688
| null | null | 0.399963
| 0.899902
| 142
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 284
| 1
|
73.52795
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 44,709.406
| 26,464.9844
| null | 37
|
white
| 31.597656
| 44
| 0.557983
| 0.444946
| 6
| 1
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 3
| 51
| 9.5
| 114
| 30
| 39.09375
| 162.5
| null | null | 1.199951
| 154
| 7.339844
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 7
| 1
|
61.37399
|
male
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 3,351.299
| 2,423.291
| null | 4
|
white
| 20
| 13
| 0.780884
| 0.540894
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.3
|
no dnr
| 4
| 83
| 14.099609
| 75
| 16
| 35.69531
| 342.8125
| null | 1.699951
| 0.599976
| 140
| 7.489258
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 40
| 1
|
66.52698
|
female
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 26
| 82,417.812
| 52,280.0625
| null | 50.666657
|
white
| 33.296875
| 42
| 0.419983
| 0.300964
| 1
| 0
| 0
|
yes
| 0.5
| 0.3
|
dnr after sadm
| 8
| 50
| 8.699219
| 110
| 25
| 35.69531
| 111.65625
| 2.699707
| 0.299988
| 1.099854
| 141
| 7.339844
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 17
| 1
|
59.60599
|
male
| 0
| 75
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 142,387.875
| 93,420.625
| null | 27
|
white
| 19.597656
| 18
| 0.856934
| 0.807983
| 3
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 75
| 110
| 13.798828
| 96
| 8
| 38.19531
| 316.625
| 2.799805
| 4.299805
| 1.299805
| 142
| 7.439453
| null | null | null | null | 7
|
SIP>=30
| 7
| 1,483
| 0
|
54.92999
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 7,007.297
| 4,616.1367
| null | 7
|
white
| 18.097656
| 9
| 0.709961
| 0.428955
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 6
| 87
| 5.799805
| 80
| 20
| 36.5
| null | 3.299805
| 0.099991
| 0.5
| 143
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 472
| 1
|
30.07799
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 37
| 209,604.625
| 147,492.5
| null | 57
|
white
| 42.398438
| 74
| 0.329956
| 0.214996
| 11
| 0
| 0
|
no
| 0
| 0
|
no dnr
| 6
| 129
| 6.899414
| 70
| 45
| 35.39844
| 283.3125
| 4.899414
| 44.09375
| 4.799805
| 151
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 2.212891
| 6
| 1
|
71.83795
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 4
| 11
|
$11-$25k
| 0
| 4,572.348
| 3,001.1348
| null | 9
|
white
| 23.199219
| 26
| 0.541992
| 0.219971
| 1
| 1
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 6
| 99
| 5.599609
| 96
| 24
| 36.79688
| null | 3.399902
| 8.798828
| 0.799927
| 139
| null | null | null | null | null | 0
| null | 0
| 264
| 1
|
83.21997
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 118,611.438
| 71,038.4375
| null | 33
|
white
| 56.09375
| 75
| 0.003
| 0
| 16
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 28
| 11.398438
| 70
| 24
| 38.5
| 184
| null | 27
| 5.399414
| 152
| 7.379883
| null | null | null | null | null |
<2 mo. follow-up
| 2.294434
| 4
| 1
|
69.60999
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 3
|
under $11k
| 0
| 10,542.648
| 7,303.0156
| null | 25.5
|
other
| 19.097656
| 23
| 0.856934
| 0.764893
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 10
| 80
| 6.899414
| 60
| 24
| 36.59375
| null | null | null | 2
| 143
| null | null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 174
| 1
|
65.65399
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 76,424.625
| 45,303.5
| null | 25.666656
|
white
| 31.597656
| 39
| 0.610962
| 0.504883
| 5
| 0
| 0
|
no
| 0.5
| 0.45
|
no dnr
| 17
| 133
| 10.199219
| 11.398438
| 36
| 38.79688
| 137.5
| null | null | 0.799927
| 136
| 7.509766
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,478
| 0
|
72.797
|
female
| 0
| 76
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 168,419.875
| 104,400.125
| null | 39.5
|
white
| 33.09375
| 64
| 0.593994
| 0.485962
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 7
| 66
| 4.699219
| 130
| 10
| 35.89844
| 260
| 1.899902
| 12.898438
| 1.399902
| 149
| 7.449219
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.043945
| 1,478
| 0
|
77.46198
|
male
| 0
| 77
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$11-$25k
| 44
| 237,865.75
| 151,713.375
| null | 41.25
|
white
| 30.796875
| 51
| 0.274963
| 0.166992
| 32
| 0
| 0
|
no
| 0.3
| 0.2
|
dnr after sadm
| 38
| 117
| 22.199219
| 118
| 10
| 35.39844
| 230
| 1.599854
| 0.5
| 3.599609
| 149
| 7.489258
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 107
| 1
|
71.06097
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 15
| null | 0
| 10,342.977
| 7,143
| null | 13.5
|
white
| 22.898438
| 25
| 0.796997
| 0.67395
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 10
| 90
| 10.699219
| 126
| 28
| 38
| 200
| null | null | 0.899902
| 134
| 7.419922
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,460
| 0
|
68.73395
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 16,283.492
| 10,915.9531
| null | 16
|
white
| 28.199219
| 25
| 0.704956
| 0.615967
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 97
| 3.799805
| 110
| 25
| 38.29688
| 126.51562
| null | null | 0.899902
| 139
| 7.439453
| null | null | null | 0
| null | null | 0.4948
| 1,458
| 0
|
40.92499
|
female
| 0
| 19
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
>$50k
| 0
| 53,731.688
| 33,714.9375
| null | 29.333328
|
white
| 33.296875
| 31
| 0.440979
| 0.32196
| 5
| 0
| 0
|
yes
| null | null |
no dnr
| 19
| 63
| 11.699219
| 120
| 14
| 36.09375
| 74.28125
| null | 0.699951
| 0.599976
| 143
| 7.509766
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 113
| 1
|
61.74399
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 6
|
under $11k
| 26
| 26,100.234
| 16,942.4375
| null | 27.5
|
white
| 21.5
| 28
| 0.787964
| 0.718994
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 6
| 137
| 12.599609
| 60
| 10
| 35
| 230
| 2.099609
| 0.099991
| 0.799927
| 147
| 7.5
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
61.405
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 5,310.949
| 3,328.5
| null | 9
|
white
| 16.398438
| 12
| 0.727905
| 0.454956
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 120
| 20.597656
| 86
| 20
| 36.19531
| null | null | 0.299988
| 1.099854
| 141
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 784
| 1
|
25.00999
|
male
| 0
| 116
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| null | null | null | 19.25
|
black
| 22.398438
| 23
| 0.910889
| 0.87793
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 116
| 69
| 12.298828
| 104
| 11
| 36.19531
| 352
| 2.399902
| 4
| 1.199951
| 137
| 7.359375
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,455
| 0
|
46.702
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
>$50k
| 0
| 61,325.469
| 36,784.6875
| null | 25
|
white
| 17.597656
| 19
| 0.902954
| 0.868896
| 3
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 16
| 73
| 11.199219
| 74
| 24
| 38.29688
| 177.5
| 2.399902
| null | 1.299805
| 136
| 7.449219
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,454
| 0
|
78.98999
|
female
| 0
| 24
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 11
|
under $11k
| 0
| 40,662.344
| 26,147.1562
| null | 20
|
white
| 18.097656
| 26
| 0.772949
| 0.637939
| 1
| 0
| 0
|
yes
| 0.8
| 0.3
|
no dnr
| 24
| 65
| null | 96
| 8
| 36.29688
| 326.625
| null | null | 1.599854
| 139
| 7.369141
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 224
| 1
|
80.45197
|
female
| 1
| 19
|
Colon Cancer
|
Cancer
| 1
| 16
| null | 0
| 9,865.195
| 7,908.918
| null | 8.333328
|
white
| 34.195313
| 33
| 0.379944
| 0.090988
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 6
| 89
| 13.898438
| 86
| 20
| 36.39844
| null | 2.5
| 11.199219
| 1.199951
| 140
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.102051
| 19
| 1
|
50.88599
|
male
| 1
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 45,795.031
| 27,621.7188
| null | 49.5
|
white
| 27.796875
| 40
| 0.635986
| 0.532959
| 1
| 0
| 0
|
yes
| 0.2
| 0.2
|
no dnr
| 10
| 67
| 6.5
| 134
| 30
| 38.5
| 98.65625
| 2.199707
| 0.399963
| 0.799927
| 141
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 2.132813
| 10
| 1
|
68.39996
|
male
| 0
| 28
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 7
|
under $11k
| 0
| 76,318.688
| 50,595.25
| null | 31.5
|
black
| 32.898438
| 56
| 0.381958
| 0.263977
| 7
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 28
| 121
| 3.399902
| 140
| 8
| 39.79688
| 167.5
| 1.5
| 0.5
| 2.199707
| 148
| 7.529297
| null | null | null | null | 5
|
no(M2 and SIP pres)
| 5
| 1,346
| 1
|
59.35898
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 19,767.641
| 13,664.2031
| null | 20.5
|
white
| 22.898438
| 18
| 0.858887
| 0.767944
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 11
| 113
| 13.5
| 110
| 24
| 36.5
| 220
| 3.199707
| 0.099991
| 0.699951
| 147
| 7.399414
| null | null | null | 0
| 4
|
no(M2 and SIP pres)
| 4
| 499
| 1
|
30.33299
|
female
| 1
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 0
| 191,009.625
| 119,011.625
| null | 37.5
|
white
| 28.699219
| 35
| 0.851929
| 0.800903
| 1
| 0
| 0
|
no
| 0.3
| 0.3
|
dnr after sadm
| 42
| 113
| 11.599609
| 130
| 28
| 39
| 132.71875
| 2
| 0.199982
| 0.599976
| 143
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 43
| 1
|
64.82996
|
male
| 0
| 62
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 213,969.625
| 141,854
| null | 39
|
white
| 29.097656
| 45
| 0.723999
| 0.638916
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 62
| 145
| 5.599609
| 186
| 8
| 38
| 91
| null | 0.899902
| 0.699951
| 142
| 7.369141
| null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 724
| 1
|
68.75
|
female
| 1
| 10
|
Coma
|
Coma
| 2
| 8
|
>$50k
| 0
| 36,883.469
| 23,581.6719
| null | 36.5
|
black
| 25.796875
| 44
| 0.615967
| 0.552979
| 1
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 9
| 70
| 14.5
| 108
| 8
| 36.19531
| 423.3125
| 1.199951
| 0.299988
| 3
| 134
| 7.449219
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 10
| 1
|
83.79999
|
male
| 0
| 12
|
Lung Cancer
|
Cancer
| 2
| 16
|
under $11k
| 9
| 6,363.598
| 5,015.9961
| null | 4
|
white
| 18.199219
| 17
| 0.596924
| 0.277954
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.5
|
no dnr
| 12
| 99
| 5.899414
| 80
| 16
| 36.19531
| null | 3.199707
| 0.5
| 1.199951
| 145
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 598
| 1
|
64.698
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 8,570.148
| 5,568.0586
| null | 9
|
white
| 11.699219
| 6
| 0.87793
| 0.723999
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 7
| 119
| 8.898438
| 60
| 24
| 36.29688
| null | 3.899902
| 0.599976
| 0.899902
| 136
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 247
| 1
|
29.30299
|
female
| 0
| 48
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 78,111.062
| 49,858.8438
| null | 20
|
white
| 37.09375
| 53
| 0.424988
| 0.304993
| 1
| 0
| 0
|
yes
| 0.2
| 0.2
|
no dnr
| 48
| 56
| 1.099854
| 134
| 38
| 39.29688
| 414.25
| 2.299805
| 5.899414
| 0.899902
| 135
| 7.419922
| null | null | null | null | 3
|
SIP>=30
| 3
| 336
| 1
|
74.89697
|
male
| 1
| 100
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 202,651.25
| 132,608.375
| null | 26
|
white
| 32.296875
| 47
| 0.560913
| 0.447998
| 3
| 1
| 0
|
no
| 0.85
| 0.82
|
no dnr
| 100
| 103
| 14.5
| 55
| 32
| 38.5
| 108.15625
| null | null | 2.899902
| 134
| 7.459961
| null | null | null | null | null | null | 3.349609
| 100
| 1
|
60.44098
|
male
| 0
| 18
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 18
|
>$50k
| 0
| 16,636.344
| 11,546.3203
| null | 11.666664
|
white
| 23.5
| 43
| 0.72998
| 0.576904
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 14
| 63
| 7
| 74
| 22
| 36.19531
| 542.75
| 2.899902
| 1.299805
| 3.799805
| 132
| 7.269531
| null | null | null | 0
| 0
| null | 0
| 95
| 1
|
37.06198
|
female
| 0
| 48
|
MOSF w/Malig
|
ARF/MOSF
| 0
| 12
| null | 0
| 217,273.625
| 136,385
| null | 49.5
|
white
| 32.09375
| 65
| 0.505981
| 0.389954
| 3
| 0
| 0
|
yes
| 0.4
| 0.4
|
dnr after sadm
| 14
| 73
| 0.299988
| 144
| 32
| 39.29688
| 206.65625
| 1.699951
| 0.399963
| 1
| 154
| 7.379883
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 436
| 1
|
85.40997
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 19,168.188
| 12,807.8047
| null | 19
|
black
| 38.695313
| 64
| 0.257996
| 0.152985
| 8
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 4
| 70
| 42.695313
| 120
| 48
| 33.89844
| 112.23438
| null | 1.699951
| 0.799927
| 139
| 7.529297
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
35.71799
|
female
| 1
| 22
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 239,604.75
| 152,206.5
| null | 22.333328
|
white
| 29
| 60
| 0.424988
| 0.304993
| 45
| 0
| 0
|
metastatic
| 0.6
| 0.5
|
dnr after sadm
| 5
| 59
| 14.298828
| 144
| 9
| 36.79688
| 286.625
| 2.299805
| null | 5.5
| 134
| 7.289062
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 22
| 1
|
57.65097
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 8
|
under $11k
| 0
| 6,005.699
| 3,721.2285
| null | 22
|
white
| 25.796875
| 10
| 0.517944
| 0.195984
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.2
|
no dnr
| 5
| 83
| 15.599609
| 108
| 16
| 36.19531
| null | 3
| 0.299988
| 0.899902
| 135
| null | null | null | null | 3
| 1
|
no(M2 and SIP pres)
| 1
| 274
| 1
|
57.34399
|
female
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 4,947.398
| 3,368.4941
| null | 6
|
white
| 15
| 20
| 0.865967
| 0.777954
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 70
| 3.899902
| 74
| 20
| 36.79688
| null | 2.5
| 2.5
| 0.899902
| 138
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,441
| 0
|
79.05499
|
female
| 0
| 47
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 6
|
under $11k
| 0
| 60,292.469
| 38,939.5625
| null | 20
|
black
| 22.199219
| 42
| 0.758911
| 0.681885
| 3
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 47
| 87
| 9.5
| 114
| 28
| 37.79688
| 452.375
| 2.199707
| 1.099854
| 2
| 141
| 7.439453
| null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 1,441
| 0
|
52.38599
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 64,889.688
| 38,822.0312
| null | 30.5
|
black
| 31.796875
| 43
| 0.672974
| 0.577881
| 6
| 1
| 0
|
no
| null | null |
no dnr
| 12
| 65
| 11.798828
| 106
| 8
| 37.39844
| 110
| null | null | 2.899902
| 136
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 2.342285
| 59
| 1
|
19.92599
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 44
| 17,898.344
| 11,910.3516
| null | 19
|
white
| 22.597656
| 32
| 0.859985
| 0.81189
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 2
| 125
| 9.199219
| 136
| 44
| 38.69531
| 376.1875
| null | null | 0.699951
| 144
| 7.469727
| null | null | null | null | 7
| null | 7
| 1,438
| 0
|
57.72998
|
male
| 1
| 13
|
Coma
|
Coma
| 2
| 3
|
under $11k
| 100
| 125,777.25
| 86,312.9375
| null | 50
|
black
| 33.898438
| 50
| 0.017998
| 0.007
| 18
| 1
| 0
|
no
| null | null |
dnr after sadm
| 12
| 107
| 7.099609
| 136
| 8
| 35.89844
| 266.625
| 3.099609
| 7
| 4.699219
| 135
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 2.976074
| 13
| 1
|
73.13898
|
female
| 0
| 52
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
under $11k
| 26
| 140,687.375
| 90,904.1875
| null | 30
|
white
| 22.296875
| 32
| 0.646973
| 0.545898
| 14
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 52
| 107
| 12.599609
| 116
| 10
| 38.69531
| 260
| 2.399902
| 0.699951
| 1.799805
| 146
| 7.40918
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,439
| 0
|
43.90399
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 0
| 63,622.125
| 38,628.3125
| null | 40.333313
|
white
| 22
| 20
| 0.870972
| 0.824951
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 111
| 13.199219
| 68
| 10
| 38.29688
| 172.5
| null | 4.399414
| 1
| 134
| 7.399414
| null | null | null | null | null |
no(M2 and SIP pres)
| 1.974121
| 1,437
| 0
|
25.67
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 16
| null | 0
| 3,895
| 2,701.5801
| null | 8
|
white
| 34.695313
| 19
| 0.575928
| 0.254944
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
no dnr
| 5
| 81
| 3.699707
| 20
| 20
| 36.5
| null | 2.299805
| 0.299988
| 0.899902
| 139
| null | null | null | null | 1
| null | null | 1.1669
| 229
| 1
|
80.13696
|
female
| 0
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
$25-$50k
| 9
| 54,550.188
| 36,936.5938
| null | 16.5
|
white
| 24.898438
| 31
| 0.650879
| 0.55188
| 5
| 0
| 0
|
no
| null | null |
no dnr
| 30
| 111
| 6.199219
| 56
| 26
| 36
| 157.5
| null | null | 0.799927
| 140
| 7.479492
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 621
| 1
|
70.57898
|
male
| 0
| 81
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 176,328
| 110,634.125
| null | 19.5
|
white
| 24.699219
| 30
| 0.712891
| 0.625
| 11
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 81
| 129
| 4.799805
| 68
| 9
| 36.69531
| 142
| 2
| 1.599854
| 0.899902
| 132
| 7.519531
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 617
| 1
|
86.35999
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 7,843.297
| 5,713.1523
| null | 11
|
white
| 18.898438
| 34
| 0.803955
| 0.682983
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 61
| 6.399414
| 56
| 16
| 35.69531
| 442.8125
| null | null | 1.099854
| 134
| 7.469727
| null | null | null | null | null | null | 3.556152
| 741
| 1
|
40.74698
|
male
| 0
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 7
|
$11-$25k
| 0
| 10,535.398
| 6,943.8008
| null | 9
|
white
| 22.398438
| 26
| 0.851929
| 0.756958
| 1
| 1
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 9
| 103
| 4.399414
| 100
| 20
| 36.79688
| null | 2.5
| 1.5
| 1.5
| 127
| null | null | null | null | 0
| 1
|
<2 mo. follow-up
| 1
| 46
| 1
|
54.86398
|
male
| 0
| 14
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null | null | 9
| 16,353.844
| 10,914.2969
| null | 11.666664
|
white
| 27.699219
| 37
| 0.652954
| 0.475952
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 9
| 83
| 8.199219
| 106
| 24
| 36.19531
| 347.5625
| 2
| 11.199219
| 0.899902
| 130
| 7.529297
| null | null | null | 1
| 2
| null | 2
| 1,434
| 0
|
60.46799
|
male
| 1
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| null | null | 0
| 15,643.797
| 10,127.2734
| null | 35
|
white
| 34.695313
| 40
| 0.662964
| 0.487976
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 4
| 115
| 13
| 139
| 32
| 37.69531
| 256.625
| 1.299805
| 0.299988
| 1.399902
| 138
| 7.349609
| null | null | null | null | null |
<2 mo. follow-up
| 3.439941
| 5
| 1
|
57.49799
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| 9
|
under $11k
| 0
| 7,245.699
| 5,296.6523
| null | 9.5
|
white
| 34.59375
| 14
| 0.460999
| 0.146973
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 4
| 83
| 5.299805
| 94
| 20
| 36.19531
| null | 2.099609
| 0.199982
| 0.399963
| 136
| null | null | null | null | 3
| 3
|
adl>=4 (>=5 if sur)
| 3
| 74
| 1
|
68.45197
|
female
| 0
| 11
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 18,796.734
| 12,338.3828
| null | 9.5
|
white
| 18.699219
| 27
| 0.785889
| 0.549927
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 2
| 75
| 2.799805
| 60
| 10
| 38.29688
| 358.3125
| 3.399902
| null | 0.699951
| 134
| 7.5
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 356
| 1
|
39.67697
|
male
| 0
| 14
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 14,717.844
| 10,088.6016
| null | 7
|
black
| 22.5
| 45
| 0.855957
| 0.761963
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 5
| 88
| 6.199219
| 106
| 28
| 37.69531
| 285.6875
| 1.599854
| 5.399414
| 1
| 133
| 7.449219
| null | null | null | 0
| 7
|
SIP>=30
| 7
| 69
| 1
|
60.81897
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 5
|
under $11k
| 0
| 25,250.438
| 15,713.0938
| null | 22
|
other
| 30.097656
| 31
| 0.716919
| 0.559937
| 2
| 0
| 0
|
no
| 0.5
| 0.2
|
no dnr
| 12
| 113
| 9.398438
| 64
| 22
| 36.79688
| 300
| 1.799805
| 0.699951
| 1.699951
| 130
| 7.439453
| null | null | null | 6
| 6
|
SIP>=30
| 6
| 194
| 1
|
66.70795
|
male
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
| null | 41
| 125,133.938
| 77,324.25
| null | 50
|
white
| 34.09375
| 76
| 0.314941
| 0.201996
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 22
| 56
| 15.199219
| 124
| 46
| 38.29688
| 116
| 2.699707
| 0.299988
| 9.599609
| 138
| 7.5
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 23
| 1
|
76.43298
|
female
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
$11-$25k
| 0
| 38,696.375
| 27,296.1406
| null | 17.75
|
white
| 19.898438
| 29
| 0.802979
| 0.737915
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 28
| 115
| 10.298828
| 66
| 6
| 38.39844
| 428.5625
| null | null | 6.899414
| 136
| 7.379883
| null | null | null | null | 1
| null | 1
| 197
| 1
|
47.21997
|
male
| 1
| 12
|
Coma
|
Coma
| 1
| 12
| null | 100
| 30,785.938
| 21,102.9844
| null | 31
|
black
| 19.097656
| 47
| 0.500977
| 0.429993
| 2
| 0
| 0
|
no
| 0.01
| 0.000001
|
dnr after sadm
| 7
| 150
| 7.099609
| 70
| 10
| 38.69531
| 388
| 1.799805
| 0.799927
| 5.299805
| 145
| 7.459961
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 12
| 1
|
43.05798
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
|
$25-$50k
| 0
| 56,844.312
| 36,040.0625
| null | 21.333328
|
hispanic
| 29.5
| 44
| 0.745972
| 0.665894
| 11
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 15
| 118
| 20.796875
| 104
| 52
| 37.79688
| 200
| 2.299805
| 7.459961
| 1.199951
| 137
| 7.419922
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,430
| 0
|
88.94495
|
female
| 1
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
under $11k
| 37
| 54,263.375
| 32,871.2812
| null | 36.666657
|
white
| 19.597656
| 31
| 0.666992
| 0.569946
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 12
| 107
| 6.799805
| 124
| 28
| 38.5
| 290
| 2.799805
| null | 0.899902
| 142
| 7.40918
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 15
| 1
|
62.31598
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
| null | 0
| 18,113.938
| 13,517.5469
| null | 10.5
|
black
| 21.097656
| 38
| 0.850952
| 0.799927
| 1
| 0
| 0
|
no
| 0.6
| 0.8
|
no dnr
| 12
| 117
| 24
| 104
| 32
| 36.39844
| 300
| 2.299805
| 0.399963
| 1.399902
| 141
| 7.439453
| null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 147
| 1
|
90.95996
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 26
| 18,570.594
| 12,917.6016
| null | 31
|
white
| 34.296875
| 65
| 0.213989
| 0.117996
| 8
| 0
| 0
|
no
| 0.3
| 0.3
|
dnr after sadm
| 1
| 107
| 8.398438
| 154
| 54
| 36.19531
| 105.70312
| null | null | 0.699951
| 151
| 7.419922
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 5
| 1
|
84.17798
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null |
under $11k
| 9
| 3,358.498
| 2,412.7949
| null | 9
|
white
| 27.796875
| 53
| 0.546997
| 0.348999
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 4
| 93
| 29
| 120
| 28
| 36.19531
| 204.75
| null | 0.399963
| 1.799805
| 143
| 7.339844
| null | null | null | null | null |
no(M2 and SIP pres)
| 4.366211
| 225
| 1
|
66.00696
|
male
| 0
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 5
|
under $11k
| 0
| 3,166.85
| 2,237.1016
| null | 1
|
black
| 21.796875
| 35
| 0.7229
| 0.567993
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 100
| 7.599609
| 60
| 28
| 35.69531
| null | 2.199707
| 3.399902
| 0.799927
| 136
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 349
| 1
|
78.05896
|
female
| 1
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 44
| 171,969.5
| 105,160.625
| null | 34.25
|
black
| 38.5
| 68
| 0.056999
| 0.018997
| 11
| 1
| 0
|
yes
| 0.25
| 0.15
|
dnr after sadm
| 20
| 50
| 23
| 100
| 32
| 38
| 131.09375
| 3.299805
| 2.899902
| 6.199219
| 136
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 3.15332
| 25
| 1
|
85.06195
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 12
|
under $11k
| 0
| 4,003.299
| 2,980.1953
| null | 4
|
white
| 23.597656
| 31
| 0.73291
| 0.581909
| 1
| 0
| 0
|
no
| 0.5
| 0.45
|
dnr after sadm
| 3
| 107
| 8
| 52
| 36
| 35.39844
| null | 3.099609
| 0.799927
| 1
| 139
| null | null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 42
| 1
|
45.89499
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 9
|
under $11k
| 0
| 18,237.391
| 13,212.0156
| null | 9.5
|
white
| 17.796875
| 17
| 0.915894
| 0.85791
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 75
| 7.899414
| 76
| 16
| 35.79688
| 272
| null | null | 0.699951
| 134
| 7.479492
| null | null | null | 0
| null | null | 0.4948
| 377
| 1
|
36.64899
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 14
|
$11-$25k
| 0
| 5,317.398
| 3,209.3789
| null | 11
|
white
| 17.296875
| 12
| 0.763916
| 0.512939
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 70
| 8
| 104
| 20
| 36.79688
| null | null | 0.099991
| 0.699951
| 136
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.995361
| 244
| 1
|
57.81799
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 5,601.098
| 3,373.2715
| null | 18
|
white
| 21.199219
| 16
| 0.635986
| 0.325989
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 104
| 11.298828
| 120
| 20
| 36.09375
| null | null | 0.199982
| 0.799927
| 141
| null | null | null | null | 2
| 4
|
no(M2 and SIP pres)
| 4
| 113
| 1
|
53.66998
|
male
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 8
| null | 0
| 18,630.891
| 12,266.3672
| null | 16
|
white
| 18.398438
| 20
| 0.916992
| 0.859985
| 1
| 0
| 0
|
no
| 0.99
| 0.95
|
no dnr
| 13
| 77
| 16.398438
| 72
| 24
| 35.5
| 240
| null | null | 1.199951
| 141
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,422
| 0
|
75.76196
|
female
| 0
| 26
|
Colon Cancer
|
Cancer
| 2
| 6
| null | 0
| 20,179.938
| 14,588.6016
| null | 12.5
|
white
| 24.296875
| 38
| 0.66394
| 0.362
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.4
|
no dnr
| 26
| 130
| 10.298828
| 120
| 32
| 40.09375
| 423.75
| 3.299805
| 0.299988
| 0.799927
| 143
| 7.489258
| null | null | null | 1
| 1
|
SIP>=30
| 1
| 137
| 1
|
60.38898
|
male
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
| null | 0
| 61,711.688
| 42,741.7188
| null | 15
|
white
| 20.5
| 20
| 0.838989
| 0.783936
| 4
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 25
| 125
| 18.597656
| 124
| 9
| 39
| 348
| 2.699707
| null | 0.899902
| 141
| 7.5
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,422
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.